{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:06:53Z","timestamp":1787170013411,"version":"build-2736575974"},"reference-count":63,"publisher":"JLE","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Dermatol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1684\/ejd.2019.3552","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T11:29:03Z","timestamp":1696850943000},"page":"294-301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Assessing the psychological burden of patients with hidradenitis suppurativa"],"prefix":"10.1684","volume":"29","author":[{"given":"Verena G.","family":"Frings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Gl\u00f6ditzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Goebeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Presser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18929","published-online":{"date-parts":[[2019,9,25]]},"reference":[{"key":"3552_CR1","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1001\/jamapsychiatry.2015.2688","volume":"73","author":"KM Scott","year":"2016","unstructured":"Scott KM, Lim C, Al-Hamzawi A, et al. Association of mental disorders with subsequent chronic physical conditions: world mental health surveys from 17 countries. JAMA Psychiatry 2016; 73: 150\u20138.","journal-title":"JAMA Psychiatry"},{"key":"3552_CR2","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1017\/S0033291718000363","volume":"48","author":"KM Scott","year":"2018","unstructured":"Scott KM, Saha S, Lim CCW, et al. Psychotic experiences and general medical conditions: a cross-national analysis based on 28 002 respondents from 16 countries in the WHO World Mental Health Surveys. Psychol Med 2018; 48: 2730\u20139.","journal-title":"Psychol Med"},{"key":"3552_CR3","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1017\/S0033291716001665","volume":"46","author":"RP Auerbach","year":"2016","unstructured":"Auerbach RP, AlonsoJ RP, Axinn WG, et al. Mental disorders among college students in the WHO World Mental Health Surveys. Psychol Med 2016; 46: 2955\u201370.","journal-title":"Psychol Med"},{"key":"3552_CR4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/archgenpsychiatry.2010.180","volume":"68","author":"RC Kessler","year":"2011","unstructured":"Kessler RC, Ormel J, Petukhova M, et al. Development of lifetime comorbidity in the World Health Organization world mental health surveys. Arch Gen Psychiatry 2011; 68: 90\u2013100.","journal-title":"Arch Gen Psychiatry"},{"key":"3552_CR5","doi-asserted-by":"publisher","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","volume":"3","author":"CD Mathers","year":"2006","unstructured":"Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3: e442.","journal-title":"PLoS Med"},{"key":"3552_CR6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.0105-1873.2006.00783.x","volume":"54","author":"RS Cvetkovski","year":"2006","unstructured":"Cvetkovski RS, Zachariae R, Jensen H, et al. Quality of life and depression in a population of occupational hand eczema patients. Contact Dermatitis 2006; 54: 106\u201311.","journal-title":"Contact Dermatitis"},{"key":"3552_CR7","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.jaad.2008.07.013","volume":"59","author":"F Dalgard","year":"2008","unstructured":"Dalgard F, Gieler U, Holm J\u00d8, et al. Self-esteem and body satisfaction among late adolescents with acne: results from a population survey. J Am Acad Dermatol 2008; 59: 746\u201351.","journal-title":"J Am Acad Dermatol"},{"key":"3552_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1468-3083.2012.04468.x","volume":"27","author":"AJ Onderdijk","year":"2013","unstructured":"Onderdijk AJ, Van der Zeek HH, Esmann S, et al. Depression in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2013; 27: 473\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3552_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jad.2013.11.009","volume":"155","author":"L Sanna","year":"2014","unstructured":"Sanna L, Stuart AL, Pasco JA, et al. Atopic disorders and depression: findings from a large, population-based study. J Affect Disord 2014; 155: 261\u20135.","journal-title":"J Affect Disord"},{"key":"3552_CR10","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/jid.2013.508","volume":"134","author":"EA Dowlatshahi","year":"2014","unstructured":"Dowlatshahi EA, Wakkee M, Arends LR, Nijsten T. The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis. J Invest Dermatol 2014; 134: 1542\u201351.","journal-title":"J Invest Dermatol"},{"key":"3552_CR11","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1600-0536.2012.02062.x","volume":"67","author":"D Boehm","year":"2012","unstructured":"Boehm D, Schmid-Ott G, Finkeldey F, et al. Anxiety, depression and impaired health-related quality of life in patients with occupational hand eczema. Contact Dermatitis 2012; 67: 184\u201392.","journal-title":"Contact Dermatitis"},{"key":"3552_CR12","first-page":"891","volume":"146","author":"SK Kurd","year":"2010","unstructured":"Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol 2010; 146: 891\u20135.","journal-title":"Arch Dermatol"},{"key":"3552_CR13","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1038\/jid.2014.70","volume":"134","author":"JA Halvorsen","year":"2014","unstructured":"Halvorsen JA, Lien L, Dalgard F, et al. Suicidal ideation, mental health problems, and social function in adolescents with eczema: a population-based study. J Invest Dermatol 2014; 134: 1847\u201354.","journal-title":"J Invest Dermatol"},{"key":"3552_CR14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/jid.2010.264","volume":"131","author":"JA Halvorsen","year":"2011","unstructured":"Halvorsen JA, Stern RS, Dalgard F, et al. Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population-based study. J Invest Dermatol 2011; 131: 363\u201370.","journal-title":"J Invest Dermatol"},{"key":"3552_CR15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1001\/archgenpsychiatry.2010.35","volume":"67","author":"AL Bayers","year":"2010","unstructured":"Bayers AL, Yaffe K, Covinsky KE, et al. High occurrence of mood and anxiety disorders among older adults. Arch Gen Psychiatry 2010; 67: 489\u201396.","journal-title":"Arch Gen Psychiatry"},{"key":"3552_CR16","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/da.20670","volume":"27","author":"SM B\u00f6gels","year":"2010","unstructured":"B\u00f6gels SM, Alden L, Beidel DC, et al. Social anxiety disorder: questions and answers for the DSM-V. Depress Anxiety 2010; 27: 168\u201389.","journal-title":"Depress Anxiety"},{"key":"3552_CR17","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age of onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593\u2013602.","journal-title":"Arch Gen Psychiatry"},{"key":"3552_CR18","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1610-0387.2012.08006.x","volume":"10","author":"CC Zouboulis","year":"2012","unstructured":"Zouboulis CC, Bechara FG, Fritz K, et al. Deutsche Dermatologische Gesellschaft; Berufsverband Deutscher Dermatologen; Deutsche Gesellschaft f\u00fcr Koloproktologie; Deutsche Gesellschaft f\u00fcr Dermatochirugie; Hidradenitis Suppurativa Foundation; Deutsche Interessegemeinschaft Akne inversa; Deutsche Gesellschaft f\u00fcr Psychosomatische Medizin; European Society of Dermatology and Psychiatry; European Society of Laser Dermatology. S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa (number ICD-10 L73.2). J Dtsch Dermatol Ges 2012; 10: S1\u201331.","journal-title":"J Dtsch Dermatol Ges"},{"key":"3552_CR19","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000431175","volume":"231","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis CC, Del Marmol V, Mrowietz U, et al. Hidradenitis suppurativa\/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation. Dermatology 2015; 231: 184\u201390.","journal-title":"Dermatology"},{"key":"3552_CR20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/jdv.12567","volume":"29","author":"E Shavit","year":"2015","unstructured":"Shavit E, Dreiher J, Freud T, et al. Psychiatric comorbidities in 3,207 patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2015; 29: 371\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3552_CR21","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2340\/00015555-1082","volume":"91","author":"S Esmann","year":"2011","unstructured":"Esmann S, Jemec GB. Psychosocial impact of hidradenitis suppurativa: a qualitative study. Acta Derm Venereol 2011; 91: 328\u201332.","journal-title":"Acta Derm Venereol"},{"key":"3552_CR22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.2340\/00015555-0866","volume":"90","author":"L Matusiak","year":"2010","unstructured":"Matusiak L, Bieniek A, Szepietowski JC. Psychophysical aspects of hidradenitis suppurativa. Acta Derm Venereol 2010; 90: 264\u20138.","journal-title":"Acta Derm Venereol"},{"key":"3552_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.det.2015.07.003","volume":"34","author":"IE Deckers","year":"2016","unstructured":"Deckers IE, Kimball AB. The handicap of hidradenitis suppurativa. Dermatol Clin 2016; 34: 17\u201322.","journal-title":"Dermatol Clin"},{"key":"3552_CR24","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1046\/j.1365-2133.2001.04137.x","volume":"144","author":"JM von der Werth","year":"2001","unstructured":"von der Werth JM, Jemec GB. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol 2001; 144: 809\u201313.","journal-title":"Br J Dermatol"},{"key":"3552_CR25","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jaad.2006.08.061","volume":"56","author":"P Wolkenstein","year":"2007","unstructured":"Wolkenstein P, Loundou A, Barrau K, et al. Quality of Life Group of the French Society of Dermatology. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol 2007; 56: 621\u20133.","journal-title":"J Am Acad Dermatol"},{"key":"3552_CR26","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/AJP.0b013e3181ceb80c","volume":"26","author":"HS Smith","year":"2010","unstructured":"Smith HS, Chao JD, Teitelbaum J. Painful hidradenitis suppurativa. Clin J Pain 2010; 26: 435\u201344.","journal-title":"Clin J Pain"},{"key":"3552_CR27","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1111\/bjd.14975","volume":"176","author":"IC Janse","year":"2017","unstructured":"Janse IC, Deckers IE, van der Maten AD, et al. Sexual health and quality of life are impaired in hidradenitis suppurativa: a multicenter cross-sectional study. Br J Dermatol 2017; 176: 1042\u20137.","journal-title":"Br J Dermatol"},{"key":"3552_CR28","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jaad.2011.10.024","volume":"67","author":"A Kurek","year":"2012","unstructured":"Kurek A, Peters EM, Chanwangpong A, et al. Profound disturbances of sexual health in patients with acne inversa. J Am Acad Dermatol 2012; 67: 422\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"3552_CR29","first-page":"729","volume-title":"Dermatologic Surgery","author":"H Hurley","year":"1989","unstructured":"Hurley H. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach. In: Dermatologic Surgery. Roenigk RK, Roenigk HH Jr. New York: Marcel Dekker, 1989: 729\u201339"},{"key":"3552_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1046\/j.1365-2133.2003.05390.x","volume":"149","author":"K Sartorius","year":"2003","unstructured":"Sartorius K, Lapins J, Emtestam L, Jemec GB. Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol 2003; 149: 211\u20133.","journal-title":"Br J Dermatol"},{"key":"3552_CR31","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin and Exp Dermatol 1994; 19: 210\u20136.","journal-title":"Clin and Exp Dermatol"},{"key":"3552_CR32","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/archderm.1997.03890470111018","volume":"133","author":"MM Chren","year":"1997","unstructured":"Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997; 133: 1433\u201340.","journal-title":"Arch Dermatol"},{"key":"3552_CR33","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1001\/jama.1994.03520080061045","volume":"272","author":"TM Gill","year":"1994","unstructured":"Gill TM, Feinstein AR. A critical appraisal of the quality-of-life measurements. JAMA 1994; 272: 619\u201326.","journal-title":"JAMA"},{"key":"3552_CR34","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.det.2011.11.003","volume":"30","author":"MM Chren","year":"2012","unstructured":"Chren MM. The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin 2012; 30: 231\u20136, xiii.","journal-title":"Dermatol Clin"},{"key":"3552_CR35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/jcph.250","volume":"54","author":"MD Reed","year":"2014","unstructured":"Reed MD, Van Nostran W. Assessing pain intensity with the visual analog scale: a plea for uniformity. J Clin Pharmacol 2014; 54: 241\u20134.","journal-title":"J Clin Pharmacol"},{"key":"3552_CR36","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361\u201370.","journal-title":"Acta Psychiatr Scand"},{"key":"3552_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1744-859X-7-4","volume":"7","author":"I Michopoulos","year":"2008","unstructured":"Michopoulos I, Douzenis A, Kalkavoura C, et al. Hospital Anxiety and Depression Scale (HADS): validation in a Greek general hospital sample. Ann Gen Psychiatry 2008; 7: 4.","journal-title":"Ann Gen Psychiatry"},{"key":"3552_CR38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1055\/s-2001-13279","volume":"51","author":"A Hinz","year":"2001","unstructured":"Hinz A, Schwarz R. Anxiety and depression in the general population: normal values in the Hospital Anxiety and Depression Scale. Psychother Psychosom Med Psychol 2001; 51: 193\u2013200.","journal-title":"Psychother Psychosom Med Psychol"},{"key":"3552_CR39","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/bmj.292.6516.344","volume":"292","author":"RP Snaith","year":"1986","unstructured":"Snaith RP, Zigmond AS. The Hospital Anxiety and Depression Scale. BMJ 1986; 292: 344.","journal-title":"BMJ"},{"key":"3552_CR40","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","volume":"112","author":"J Cohen","year":"1992","unstructured":"Cohen J. A power primer. Psychol Bull 1992; 112: 155\u20139.","journal-title":"Psychol Bull"},{"key":"3552_CR41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1159\/000358009","volume":"228","author":"GR Vinding","year":"2014","unstructured":"Vinding GR, Knudsen KM, Ellervik C, Olesen AB, Jemec GB. Self-reported skin morbidities and health-related quality of life: a population-based nested case-control study. Dermatology 2014; 228: 261\u20138.","journal-title":"Dermatology"},{"key":"3552_CR42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.det.2015.08.002","volume":"34","author":"IM Miller","year":"2016","unstructured":"Miller IM, McAndrew RJ, Hamzavi I. Prevalence, risk factors, and comorbidities of hidradenitis suppurativa. Dermatol Clin 2016; 34: 7\u201316.","journal-title":"Dermatol Clin"},{"key":"3552_CR43","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1001\/jamadermatol.2017.3596","volume":"153","author":"JS Kirby","year":"2017","unstructured":"Kirby JS, Butt M, Esmann S, Jemec GBE. Association of resilience with depression and health-related quality of life for patients with hidradenitis suppurativa. JAMA Dermatol 2017; 153: 1263\u20139.","journal-title":"JAMA Dermatol"},{"key":"3552_CR44","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1159\/000453355","volume":"232","author":"A Kouris","year":"2016","unstructured":"Kouris A, Platsidaki E, Christodoulou C, et al. Quality of life and psychosocial implications in patients with hidradenitis suppurativa. Dermatology 2016; 232: 687\u201391.","journal-title":"Dermatology"},{"key":"3552_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/jid.2012.255","volume":"133","author":"BG Vazquez","year":"2013","unstructured":"Vazquez BG, Alikhan A, Weaver AL, Wetter DA, Davis MD. Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted county, Minnesota. J Invest Dermatol 2013; 133: 97\u2013103.","journal-title":"J Invest Dermatol"},{"key":"3552_CR46","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jaad.2015.07.046","volume":"73","author":"B Horv\u00e1th","year":"2015","unstructured":"Horv\u00e1th B, Janse IC, Sibbald GR. Pain management in patients with hidradenitis suppurativa. J Am Acad Dermatol 2015; 73: S47\u201351.","journal-title":"J Am Acad Dermatol"},{"key":"3552_CR47","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1111\/bjd.13122","volume":"171","author":"JJ Crowley","year":"2014","unstructured":"Crowley JJ, Mekkes JR, Zouboulis CC, et al. Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities. Br J Dermatol 2014; 171: 1561\u20135.","journal-title":"Br J Dermatol"},{"key":"3552_CR48","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMcp1014163","volume":"366","author":"GB Jemec","year":"2012","unstructured":"Jemec GB. Clinical practice. Hidradenitis suppurativa. N Engl J Med 2012; 366: 158\u201364.","journal-title":"N Engl J Med"},{"key":"3552_CR49","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","volume":"164","author":"HH van der Zee","year":"2011","unstructured":"van der Zee HH, de Ruiter L, van den Broecke DG, et al. Elevated levels of tumour necrosis factor (TNF)-\u03b1, interleukin (IL)-1\u03b2and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-\u03b1and IL-1\u03b2. Br J Dermatol 2011; 164: 1292\u20138.","journal-title":"Br J Dermatol"},{"key":"3552_CR50","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1080\/13547500903075218","volume":"14","author":"L Matusiak","year":"2009","unstructured":"Matusiak L, Bieniek A, Szepietowski JC. Soluble interleukin-2 receptor serum level is a useful marker of hidradenitis suppurativa clinical staging. Biomarkers 2009; 14: 432\u20137.","journal-title":"Biomarkers"},{"key":"3552_CR51","doi-asserted-by":"publisher","first-page":"e66847","DOI":"10.1371\/journal.pone.0066847","volume":"8","author":"SY Lee","year":"2013","unstructured":"Lee SY, Chen SL, Chang YH, et al. Inflammation\u2019s association with metabolic profiles before and after a twelve-week clinical trial drugnaive patients with bipolar II disorder. PLoS ONE 2013; 8: e66847.","journal-title":"PLoS ONE"},{"key":"3552_CR52","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.jad.2011.10.002","volume":"136","author":"BE Henje","year":"2012","unstructured":"Henje BE, Lekander M, Ingvar M, et al. Pro-inflammatory cytokines are elevated in adolescent females with emotional disorders not treated with SSRIs. J Affect Disord 2012; 136: 716\u201323.","journal-title":"J Affect Disord"},{"key":"3552_CR53","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.pnpbp.2012.12.001","volume":"43","author":"DF De Souza","year":"2013","unstructured":"De Souza DF, Wartchow K, Hansen F, et al. Interleukin-6-induced S100B secretion is inhibited by haloperidol and risperidone. Prog Neuropsychopharmacol Biol Psychiatry 2013; 43: 14\u201322.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3552_CR54","doi-asserted-by":"publisher","first-page":"9009","DOI":"10.1038\/srep09009","volume":"5","author":"E Kong","year":"2015","unstructured":"Kong E, Sucic S, Monje FJ, et al. STAT3 controls IL6-dependent regulation of serotonin transporter function and depression-like behavior. Sci Rep 2015; 5: 9009.","journal-title":"Sci Rep"},{"key":"3552_CR55","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010; 67: 446\u201357.","journal-title":"Biol Psychiatry"},{"key":"3552_CR56","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.psychres.2017.05.012","volume":"254","author":"AA Memon","year":"2017","unstructured":"Memon AA, Sundquist K, Ahmad A, et al. Role of IL-8, CRP and epidermal growth factor in depression and anxiety patients treated with mindfulness-based therapy or cognitive behavioral therapy in primary health care. Psychiatry Res 2017; 254: 311\u20136.","journal-title":"Psychiatry Res"},{"key":"3552_CR57","doi-asserted-by":"publisher","first-page":"393","DOI":"10.5021\/ad.2012.24.4.393","volume":"24","author":"FG Bechara","year":"2012","unstructured":"Bechara FG, Sand M, Skrygan M, et al. Acne inversa: evaluating antimicrobial peptides and proteins. Ann Dermatol 2012; 24: 393\u20137.","journal-title":"Ann Dermatol"},{"key":"3552_CR58","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/j.1365-2133.2011.10765.x","volume":"166","author":"VU Emelianov","year":"2012","unstructured":"Emelianov VU, Bechara FG, Glaser R, et al. Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa\/acne inversa. Br J Dermatol 2012; 166: 1023\u201334.","journal-title":"Br J Dermatol"},{"key":"3552_CR59","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1097\/MD.0000000000000187","volume":"93","author":"AV Marzano","year":"2014","unstructured":"Marzano AV, Ceccherini I, Gattorno M, et al. Association of pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases. Medicine (Baltimore) 2014; 93: e187.","journal-title":"Medicine (Baltimore)"},{"key":"3552_CR60","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/bjd.13090","volume":"171","author":"CB Kromann","year":"2014","unstructured":"Kromann CB, Deckers IE, Esmann S, et al. Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: a crosssectional study. Br J Dermatol 2014; 171: 819\u201324.","journal-title":"Br J Dermatol"},{"key":"3552_CR61","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","volume":"161","author":"K Sartorius","year":"2009","unstructured":"Sartorius K, Emtestam L, Jemec GB, Lapins J. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol 2009; 161: 831\u20139.","journal-title":"Br J Dermatol"},{"key":"3552_CR62","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/bjd.14038","volume":"173","author":"DM Saunte","year":"2015","unstructured":"Saunte DM, Boer J, Stratigos A, et al. Diagnostic delay in hidradenitis suppurativa is a global problem. Br J Dermatol 2015; 173: 1546\u20139.","journal-title":"Br J Dermatol"},{"key":"3552_CR63","doi-asserted-by":"publisher","first-page":"e111420","DOI":"10.1371\/journal.pone.0111420","volume":"9","author":"AL Leppin","year":"2014","unstructured":"Leppin AL, Bora PR, Tilburt JC, et al. The efficacy of resiliency training programs: a systematic review and meta-analysis of randomized trials. PLoS One 2014; 9: e111420.","journal-title":"PLoS One"}],"container-title":["European Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2019.3552.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1684\/ejd.2019.3552\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2019.3552.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2019.3552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T11:20:45Z","timestamp":1741173645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2019.3552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["3552"],"URL":"https:\/\/doi.org\/10.1684\/ejd.2019.3552","relation":{},"ISSN":["1952-4013"],"issn-type":[{"value":"1952-4013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"30 November 2018","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}